Featured 13F manager
Nvidia Corp.
Santa Clara, CA 4 processed 13Fs on this site · 2025 Q3–2026 Q2
- $63.4B
- 8 Positions
- 2026 Q2
- +245.3% QoQ
- Top 5 96.1%
Nvidia Corp. files a Form 13F. The latest book is 2026 Q2 at $63.4B, up 245.3% QoQ, led by Intel, Space Exploration ·, and Coreweave.
Portfolio
top 5 96.1% · top 10 100.0%
- INTC - Intel 47.3%
- SPCX - Space Exploration · CLASS A 33.1%
- CRWV - Coreweave · CL A 7.4%
- COHR - Coherent 4.8%
- NOK - Nokia 3.5%
- SNPS - Synopsys 3.4%
- NBIS - Nebius Group · CLASS A 0.5%
- GENB - Generate Biomedicines 0.0%
AUM over time
Latest book
| INTC - Intel | 47.27% | Hold | 214,776,632 | $139.63 | $30B | — | — |
| SPCX - Space Exploration · CLASS A | 33.06% | New | 122,764,805 | $170.86 | $21B | +122,764,805 | +$21B |
| CRWV - Coreweave · CL A | 7.41% | Hold | 47,213,353 | $99.54 | $4.7B | — | — |
| COHR - Coherent | 4.84% | Hold | 7,788,161 | $394.47 | $3.1B | — | — |
| NOK - Nokia | 3.48% | Hold | 166,389,351 | $13.28 | $2.2B | — | — |
| SNPS - Synopsys | 3.39% | Hold | 4,821,717 | $446.07 | $2.2B | — | — |
| NBIS - Nebius Group · CLASS A | 0.52% | Hold | 1,190,476 | $276.17 | $329M | — | — |
| GENB - Generate Biomedicines | 0.02% | Hold | 833,325 | $16.87 | $14M | — | — |
Filings history
4 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 8 | $63.4B | +245.3% | 13F-HR | 8/14/2026 | 000104581026000065 |
| 2026 Q1 | 7 | $18.4B | +40.2% | 13F-HR | 5/15/2026 | 000104581026000042 |
| 2025 Q4 | 5 | $13.1B | +240.9% | 13F-HR | 2/17/2026 | 000104581026000011 |
| 2025 Q3 | 6 | $3.8B | — | 13F-HR | 11/14/2025 | 000104581025000219 |
About
Nvidia Corp.
4 processed 13Fs on this site · 2025 Q3–2026 Q2